SCHEMBL7828069

SCHEMBL7828069

Cc1oc2c(NC(=O)c3c(Cl)cccc3Cl)cccc2c1C(=O)c1ccccc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR35 Q9HC97 3/20 0.46
MAPT P10636 6/20 0.44
RAB9A P51151 6/20 0.44
ALDH1A1 P00352 5/20 0.44
LMNA P02545 5/20 0.44
NPSR1 Q6W5P4 4/20 0.44
HPGD P15428 3/20 0.44
PKM P14618 3/20 0.44
GAA P10253 1/20 0.43
POLB P06746 1/20 0.43
MEN1 O00255 3/20 0.42
KMT2A Q03164 3/20 0.42
KDM4E B2RXH2 1/20 0.42
ALOX12 P18054 1/20 0.42
NPC1 O15118 4/20 0.42
CYP1A2 P05177 2/20 0.42
CYP3A4 P08684 2/20 0.42
CYP2C9 P11712 2/20 0.42
CYP2C19 P33261 2/20 0.42
HTT P42858 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7826306 0.86 GAA (0.45) GPR35MAPTRAB9AALDH1A1LMNA
SCHEMBL8800344 0.85 EYA3 (0.44) GPR35RAB9ALMNAPKMMEN1
SCHEMBL7831814 0.84 RAB9A (0.42) GPR35MAPTRAB9AALDH1A1LMNA
SCHEMBL7823933 0.84 MAPT (0.48) GPR35MAPTRAB9AALDH1A1LMNA
SCHEMBL8341922 0.83 GPR35 (0.42) GPR35MAPTRAB9AALDH1A1LMNA
SCHEMBL7826421 0.82 ACHE (0.42) GPR35MAPTRAB9AALDH1A1LMNA
SCHEMBL7817291 0.82 RAB9A (0.41) MAPTRAB9AALDH1A1LMNANPSR1
SCHEMBL7826424 0.82 ACHE (0.42) GPR35MAPTRAB9AALDH1A1LMNA
SCHEMBL7824655 0.81 KMT2A (0.44) GPR35MAPTRAB9AALDH1A1LMNA
SCHEMBL7816264 0.81 TYK2 (0.47) MAPTRAB9AALDH1A1LMNANPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0757682-B1 BENZOFURAN DERIVATIVES USEFUL AS INHIBITORS OF BONE RESORPTION FUJISAWA PHARMACEUTICAL CO (JP) 2001-06-20 EP disclosed
US-5858995-A ADMINISTERING TO HUMANS AND ANIMALS IN THE TREATMENT OF DISEASES CAUSED BY ABNORMAL BONE METABOLISM FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1999-01-12 US disclosed